The Whole Truth
Science & Research
Latest Research
Jan 17, 2006
Zyflamend Reduces LTB4 Formulation, and May Prevent Oral Carcinogenesis, in a DMBA-induced Hamster Cheek Pouch Model
Chronic inflammation has been proposed to contribute to carcinogenesis in many organ sites such as colon, long and oral cancers.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Go Back
]






Certified Organic by International Certification Services, Inc


